Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss of $0.42
Tweet
Share
E-mailGet Alerts RAPP Hot Sheet
Join SI Premium – FREE
Rapport Therapeutics, Inc. (NASDAQ: RAPP) reported Q1 EPS of ($0.42). Revenue for the quarter came in at $20 million.
For earnings history and earnings-related data on Rapport Therapeutics, Inc. (RAPP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Marriott Vacations Worldwide (VAC) Declares $0.80 Quarterly Dividend; 3.2% Yield
- BQE Water Announces Investor Call for Fall 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
